{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:29:09Z","timestamp":1771666149795,"version":"3.50.1"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T00:00:00Z","timestamp":1290384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Autoantibodies to intracellular targets in mitochondria and nuclei are serological hallmarks of primary biliary cirrhosis (PBC). One of the most recently identified cellular targets of PBC autoantibodies is a novel cytoplasmic structure referred to as GW bodies [GWB, G (glycine) W (tryptophan)-containing bodies (GWB)]. GWB are indentified as discrete cytoplasmic domains that are involved in mRNA processing via the RNA interference (RNAi) pathway. Key components of GWB include the proteins GW182, Ago2, RNA-associated protein 55 (RAP55) and Ge-1\/Hedls. The primary objective was to study the frequency and clinical association of antibodies directed to GWB components, in 109 PBC patients. Autoantibodies to mitochondrial antigen\u2013pyruvate dehydrogenase complex (M2), branched-chain 2-oxo-acid dehydrogenase complex and 2-oxo glutarate dehydrogenase complex (3E-BPO), gp210, sp100, promyelocytic leukaemia cell antigen (PML) and liver kidney microsomal-1 antigen (LKM-1) were detected by a line immunoassay and antibodies to GWB (GW182, RAP55, Ge-1, GW2, GW3) and glutamate receptor interacting protein (GRIP)-associated protein-1 (GRASP-1), by an addressable laser bead immunoassay (ALBIA). The most common GWB autoantigen targets were: RAP55-28%, GW182-12%, GW2-2% and antibodies to GRASP-1-17%. By comparison, the frequency of reactivity to established PBC autoantigens was: gp210, 27%; sp100, 27% and PML, 17%. None of the autoantibodies were associated with differences in Mayo risk score or liver decompensation. This study is the first study to show that antibodies to RAP55, GW182 and GRASP-1 are the most common GWB targets in PBC.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04288.x","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T16:52:28Z","timestamp":1290444748000},"page":"147-156","source":"Crossref","is-referenced-by-count":43,"title":["Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis"],"prefix":"10.1093","volume":"163","author":[{"given":"L M","family":"Stinton","sequence":"first","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Swain","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R P","family":"Myers","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A A","family":"Shaheen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Fritzler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,11,22]]},"reference":[{"key":"2021122708482099300_b1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"2021122708482099300_b2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"key":"2021122708482099300_b3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cld.2008.02.009","article-title":"Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value","volume":"12","author":"Muratori","year":"2008","journal-title":"Clin Liver Dis"},{"key":"2021122708482099300_b4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"2021122708482099300_b5","first-page":"477","article-title":"The cytoplasmic dot staining pattern is detected in a subgroup of patients with primary biliary cirrhosis","volume":"32","author":"Bloch","year":"2005","journal-title":"J Rheumatol"},{"key":"2021122708482099300_b6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2007.07.016","article-title":"Clinical and serological features of patients with autoantibodies to GW\/P bodies","volume":"125","author":"Bhanji","year":"2007","journal-title":"Clin Immunol"},{"key":"2021122708482099300_b7","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1091\/mbc.01-11-0544","article-title":"A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles","volume":"13","author":"Eystathioy","year":"2002","journal-title":"Mol Biol Cell"},{"key":"2021122708482099300_b8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2005.03.021","article-title":"Identification of GRASP-1 as a novel 97\u2003kDa autoantigen localized to endosomes","volume":"116","author":"Stinton","year":"2005","journal-title":"Clin Immunol"},{"key":"2021122708482099300_b9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1261\/rna.411907","article-title":"Probing the mRNA processing body using protein macroarrays and \u2018autoantigenomics\u2019","volume":"13","author":"Yang","year":"2007","journal-title":"RNA"},{"key":"2021122708482099300_b10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"Nakamura","year":"2005","journal-title":"J Hepatol"},{"key":"2021122708482099300_b11","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.23210","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study","volume":"50","author":"Myers","year":"2009","journal-title":"Hepatology"},{"key":"2021122708482099300_b12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"2021122708482099300_b13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"2021122708482099300_b14","first-page":"224","article-title":"Autoantibody testing: procedures and significance in systemic rheumatic diseases","volume":"12","author":"Fritzler","year":"1986","journal-title":"Methods Achiev Exp Pathol"},{"key":"2021122708482099300_b15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01006401","article-title":"Detection of antibodies to DNA: a technical assessment","volume":"17","author":"Smeenk","year":"1992","journal-title":"Mol Biol Rep"},{"key":"2021122708482099300_b16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/153685903321947996","article-title":"A panel of monoclonal antibodies to cytoplasmic GW bodies and the mRNA binding protein GW182","volume":"22","author":"Eystathioy","year":"2003","journal-title":"Hybrid Hybridomics"},{"key":"2021122708482099300_b17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00109-003-0423-1","article-title":"Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins","volume":"81","author":"Mahler","year":"2003","journal-title":"J Mol Med"},{"key":"2021122708482099300_b18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00109-003-0495-y","article-title":"Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182","volume":"81","author":"Eystathioy","year":"2003","journal-title":"J Mol Med"},{"key":"2021122708482099300_b19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-3083.2006.01747.x","article-title":"Anti-p97\/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease?","volume":"63","author":"Miyachi","year":"2006","journal-title":"Scand J Immunol"},{"key":"2021122708482099300_b20","first-page":"311","article-title":"Early endosome antigen. 1: an autoantigen associated with neurological diseases","volume":"47","author":"Selak","year":"1999","journal-title":"J Invest Med"},{"key":"2021122708482099300_b21","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1261\/rna.2142405","article-title":"Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body","volume":"11","author":"Yu","year":"2005","journal-title":"RNA"},{"key":"2021122708482099300_b22","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.4049\/jimmunol.138.10.3219","article-title":"Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle","volume":"138","author":"Okada","year":"1987","journal-title":"J Immunol"},{"key":"2021122708482099300_b23","first-page":"165","article-title":"Quantification of lupus anti-ribosome P antibodies using a recombinant P2 fusion protein and determination of the predicted amino acid sequence of the autoantigen in patients' mononuclear cells","volume":"76","author":"Magsaam","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"2021122708482099300_b24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1261\/rna.2302706","article-title":"RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and stress granules","volume":"12","author":"Yang","year":"2006","journal-title":"RNA"},{"key":"2021122708482099300_b25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2249.2002.01756.x","article-title":"The cytoplasmic linker protein CLIP-170 is a human autoantigen","volume":"127","author":"Griffith","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2021122708482099300_b26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"2021122708482099300_b27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2003.10.005","article-title":"Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies","volume":"110","author":"Stinton","year":"2004","journal-title":"Clin Immunol"},{"key":"2021122708482099300_b28","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/ar1959","article-title":"Autoimmune targeting of key components of RNA interference","volume":"8","author":"Jakymiw","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"2021122708482099300_b29","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1261\/rna.5810203","article-title":"The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies","volume":"9","author":"Eystathioy","year":"2003","journal-title":"RNA"},{"key":"2021122708482099300_b30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2249.2006.03024.x","article-title":"Human autoantibodies to diacyl-phosphatidylethanolamine recognize a specific set of discrete cytoplasmic domains","volume":"143","author":"Laurino","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2021122708482099300_b31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1749-6632.1999.tb11323.x","article-title":"Characterization, expression, and distribution of GRIP protein","volume":"868","author":"Dong","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"2021122708482099300_b32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/bega.2000.0101","article-title":"Autoimmunity and primary biliary cirrhosis","volume":"14","author":"Mackay","year":"2000","journal-title":"Bailli\u00e8res Best Pract Res Clin Gastroenterol"},{"key":"2021122708482099300_b33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"2021122708482099300_b34","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1542-3565(04)00465-3","article-title":"Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?","volume":"2","author":"Yang","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021122708482099300_b35","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/00365520310004876","article-title":"Clinical significance of anti-multiple nuclear dots\/Sp100 autoantibodies","volume":"38","author":"Wichmann","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"2021122708482099300_b36","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1111\/j.1872-034X.2007.00227.x","article-title":"Nuclear envelope protein autoantigens in primary biliary cirrhosis","volume":"37","author":"Worman","year":"2007","journal-title":"Hepatol Res"},{"key":"2021122708482099300_b37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.2003.07270.x","article-title":"Positive markers in AMA-negative PBC","volume":"98","author":"Vergani","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2021122708482099300_b38","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1084\/jem.182.4.1159","article-title":"Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210","volume":"182","author":"Wesierska-Gadek","year":"1995","journal-title":"J Exp Med"},{"key":"2021122708482099300_b39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcla.20170","article-title":"Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis","volume":"21","author":"Bauer","year":"2007","journal-title":"J Clin Lab Anal"},{"key":"2021122708482099300_b40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210\u2003kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"2021122708482099300_b41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis","volume":"98","author":"Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2021122708482099300_b42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-008-0150-6","article-title":"The value of antinuclear antibodies in primary biliary cirrhosis","volume":"8","author":"Gao","year":"2008","journal-title":"Clin Exp Med"},{"key":"2021122708482099300_b43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1478-3231.2007.01651.x","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis","volume":"28","author":"Liu","year":"2008","journal-title":"Liver Int"},{"key":"2021122708482099300_b44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0171-2985(97)80051-4","article-title":"Nuclear dots: actors on many stages","volume":"198","author":"Sternsdorf","year":"1997","journal-title":"Immunobiology"},{"key":"2021122708482099300_b45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-3083.1995.tb03652.x","article-title":"Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis","volume":"42","author":"Sternsdorf","year":"1995","journal-title":"Scand J Immunol"},{"key":"2021122708482099300_b46","first-page":"1123","article-title":"Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis","volume":"26","author":"Zuchner","year":"1997","journal-title":"Hepatology"},{"key":"2021122708482099300_b47","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3899\/jrheum.090340","article-title":"Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients","volume":"36","author":"Assassi","year":"2009","journal-title":"J Rheumatol"},{"key":"2021122708482099300_b48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2177\/jsci.31.47","article-title":"Primary biliary cirrhosis and autoantibodies","volume":"31","author":"Miyachi","year":"2008","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"2021122708482099300_b49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"2021122708482099300_b50","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun Rev"},{"key":"2021122708482099300_b51","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS-A\/Ro-52\u2003kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis","volume":"26","author":"Granito","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2021122708482099300_b52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-3083.1998.00262.x","article-title":"A novel antibody directed against a three-dimensional configuration of a 95-kDa protein in patients with autoimmune hepatic diseases","volume":"47","author":"Miyachi","year":"1998","journal-title":"Scand J Immunol"},{"key":"2021122708482099300_b53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/ard.54.2.148","article-title":"Specificity of antinuclear antibodies in primary biliary cirrhosis","volume":"54","author":"Chou","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"2021122708482099300_b54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10446670410001722113","article-title":"Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis","volume":"11","author":"Benson","year":"2004","journal-title":"Clin Dev Immunol"},{"key":"2021122708482099300_b55","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1872-034X.2008.00474.x","article-title":"Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis","volume":"39","author":"Kikuchi","year":"2009","journal-title":"Hepatol Res"},{"key":"2021122708482099300_b56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","article-title":"Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis","volume":"107","author":"Czaja","year":"1994","journal-title":"Gastroenterology"},{"key":"2021122708482099300_b57","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00109-004-0554-z","article-title":"Autoantigens of the nuclear pore complex","volume":"82","author":"Enarson","year":"2004","journal-title":"J Mol Med"},{"key":"2021122708482099300_b58","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1365-2036.2006.03172.x","article-title":"Antinuclear antibodies giving the \u2018multiple nuclear dots\u2019 or the \u2018rim-like\/membranous\u2019 patterns: diagnostic accuracy for primary biliary cirrhosis","volume":"24","author":"Granito","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2021122708482099300_b59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ajg.2009.596","article-title":"PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis","volume":"105","author":"Granito","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2021122708482099300_b60","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780260714","article-title":"Anticentromere antibodies in primary biliary cirrhosis","volume":"26","author":"Makinen","year":"1983","journal-title":"Arthritis Rheum"},{"key":"2021122708482099300_b61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1346-8138.1993.tb01389.x","article-title":"Autoantibodies in scleroderma","volume":"20","author":"Fritzler","year":"1993","journal-title":"J Dermatol"},{"key":"2021122708482099300_b62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cm.970230402","article-title":"Mapping the mammalian intercellular bridge. [Review]","volume":"23","author":"Rattner","year":"1992","journal-title":"Cell Motil Cytoskeleton"},{"key":"2021122708482099300_b63","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s10620-010-1268-4","article-title":"Autoantibodies as prognostic markers in autoimmune liver disease","volume":"55","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"key":"2021122708482099300_b64","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cgh.2009.07.012","article-title":"Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease","volume":"7","author":"Milkiewicz","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021122708482099300_b65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/08916939908994755","article-title":"Detection of anti-branched chain 2-oxo acid dehydrogenase complex (BCOADC)-E2 antibody in primary biliary cirrhosis by ELISA using recombinant fusion protein","volume":"30","author":"Miyakawa","year":"1999","journal-title":"Autoimmunity"},{"key":"2021122708482099300_b66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2009.08.009","article-title":"A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis","volume":"34","author":"Agmon-Levin","year":"2010","journal-title":"J Autoimmun"},{"key":"2021122708482099300_b67","first-page":"497","article-title":"Primary Sjogren's syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile","volume":"13","author":"Tishler","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"2021122708482099300_b68","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-2001-12906","article-title":"[Presence of SLA\/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)]","volume":"126","author":"Kanzler","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"key":"2021122708482099300_b69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF02358676","article-title":"Detection of anti-double and anti-single stranded DNA antibodies in chronic liver disease: significance of anti-double stranded DNA antibody in autoimmune hepatitis","volume":"29","author":"Tsuchiya","year":"1994","journal-title":"J Gastroenterol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04288.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/163\/2\/147\/41909527\/j.1365-2249.2010.04288.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/163\/2\/147\/41909527\/j.1365-2249.2010.04288.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T12:04:27Z","timestamp":1711973067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/163\/2\/147\/6428819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,22]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,11,22]]},"published-print":{"date-parts":[[2011,1,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04288.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,2]]},"published":{"date-parts":[[2010,11,22]]}}}